SCHEMBL21496445

SCHEMBL21496445

NC(=O)Cc1ccc(N2CC[C@@]3(CCC(=O)NC3=O)C2)nc1

nearest known ligand 0.62

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 20/20 0.62
DDB1 Q16531 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21496444 1.00 CRBN (0.62) CRBNDDB1
SCHEMBL21496453 0.81 CRBN (0.68) CRBNDDB1
SCHEMBL21496486 0.80 CRBN (0.72) CRBNDDB1
SCHEMBL21496461 0.77 CRBN (0.82) CRBNDDB1
SCHEMBL22931831 0.77 CRBN (1.00) CRBNDDB1
SCHEMBL21496431 0.75 CRBN (1.00) CRBNDDB1
SCHEMBL29346902 0.75 CRBN (0.55) CRBNDDB1
SCHEMBL21496491 0.74 CRBN (1.00) CRBNDDB1
SCHEMBL29346922 0.73 CRBN (0.51) CRBNDDB1
SCHEMBL22932165 0.73 CRBN (0.65) CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3781156-A1 SPIROCYCLIC COMPOUNDS C4 Therapeutics, Inc. (US) 2021-02-24 EP disclosed
WO-2019204354-A1 SPIROCYCLIC COMPOUNDS C4 THERAPEUTICS, INC. (US) 2019-10-24 WO disclosed